ARHCF Stock - Alfresa Holdings Corporation
Unlock GoAI Insights for ARHCF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.96T | $2.86T | $2.70T | $2.59T | $2.60T |
| Gross Profit | $213.93B | $206.37B | $192.09B | $187.47B | $175.54B |
| Gross Margin | 7.2% | 7.2% | 7.1% | 7.3% | 6.7% |
| Operating Income | $38.08B | $38.46B | $30.15B | $29.09B | $20.67B |
| Net Income | $27.39B | $29.56B | $25.79B | $32.18B | $24.50B |
| Net Margin | 0.9% | 1.0% | 1.0% | 1.2% | 0.9% |
| EPS | $147.54 | $154.13 | $127.42 | $153.57 | $115.75 |
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.
Visit WebsiteEarnings History & Surprises
ARHCFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 13, 2026 | — | — | — | — |
Q1 2026 | Feb 9, 2026 | — | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.32 | $0.00 | -99.5% | ✗ MISS |
Q3 2025 | Aug 6, 2025 | $0.26 | $0.19 | -25.8% | ✗ MISS |
Q2 2025 | May 15, 2025 | $0.20 | $0.06 | -67.9% | ✗ MISS |
Q1 2025 | Feb 6, 2025 | $0.30 | $0.40 | +31.7% | ✓ BEAT |
Q4 2024 | Nov 7, 2024 | $0.27 | $0.36 | +35.1% | ✓ BEAT |
Q3 2024 | Aug 5, 2024 | $0.18 | $0.15 | -19.5% | ✗ MISS |
Q2 2024 | May 14, 2024 | $0.25 | $0.31 | +21.0% | ✓ BEAT |
Q1 2024 | Feb 8, 2024 | $0.27 | $0.34 | +30.0% | ✓ BEAT |
Q3 2023 | Sep 30, 2023 | $0.22 | $0.27 | +20.8% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | — | $0.14 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.41 | — | — |
Q1 2023 | Feb 7, 2023 | — | $0.29 | — | — |
Q4 2022 | Nov 7, 2022 | — | $0.16 | — | — |
Q3 2022 | Aug 5, 2022 | — | $0.08 | — | — |
Q2 2022 | May 16, 2022 | — | $0.51 | — | — |
Q1 2022 | Feb 7, 2022 | — | $0.49 | — | — |
Q4 2021 | Nov 4, 2021 | — | $0.16 | — | — |
Q3 2021 | Aug 5, 2021 | — | $0.14 | — | — |
Latest News
Frequently Asked Questions about ARHCF
What is ARHCF's current stock price?
What is the analyst price target for ARHCF?
What sector is Alfresa Holdings Corporation in?
What is ARHCF's market cap?
Does ARHCF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ARHCF for comparison